Location History:
- Kawagoe, JP (1999 - 2012)
- Saitama, JP (2000 - 2016)
Company Filing History:
4 out of 11 
2 out of 2 
2 out of 2 Years Active: 1999-2016
Title: Kinya Nagata: Innovator in Therapeutic Agents for Infections
Introduction
Kinya Nagata is a prominent inventor based in Saitama, Japan. He has made significant contributions to the field of medical science, particularly in developing therapeutic agents for infections. With a total of 6 patents to his name, Nagata's work focuses on innovative solutions that address critical health challenges.
Latest Patents
Nagata's latest patents include a therapeutic agent for infections that utilizes granulysin as an active ingredient. This invention aims to provide a treatment option that has minimal side effects and no cytotoxicity, while also being resistant to bacterial resistance. The therapeutic agent comprises various combinations of 15K granulysin, in vivo expression vectors, and interleukins such as IL-6, IL-23, or IL-27. This innovative approach enhances the killing effects on bacteria and offers a promising solution for treating infections.
Career Highlights
Throughout his career, Kinya Nagata has worked with notable organizations, including BML, Inc. and the National Hospital Organization Kinki-chuo Chest Medical Center. His experience in these institutions has contributed to his expertise in developing effective therapeutic agents.
Collaborations
Nagata has collaborated with esteemed colleagues, including Kazuyuki Ogawa and Syoichi Takano. These partnerships have played a vital role in advancing his research and innovations in the field of medical science.
Conclusion
Kinya Nagata's contributions to the development of therapeutic agents for infections highlight his dedication to improving healthcare solutions. His innovative patents and collaborations reflect his commitment to addressing significant medical challenges.